Samsara Opportunity Fund GP, LLC — SEC Form 4 filings

SEC reporting owner CIK 2086456. 3 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-12-22 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kalaris Therapeutics, Inc. (KLRS)10% owner32 legs · 724,147 sh · $6,179,9754

Form 4 filings — Samsara Opportunity Fund GP, LLC

FiledFormIssuerReported transactionsSource
2026-05-224Kalaris Therapeutics, Inc. (KLRS)
jointly with AKKARAJU SRINIVAS, Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P.
Purchase (P): 244,300 @ $4.83 · Other (J): 66,906 @ $0 · Other (J): 14,937 @ $0 · Other (J): 4,471 @ $0EDGAR
2026-02-174Kalaris Therapeutics, Inc. (KLRS)
jointly with AKKARAJU SRINIVAS, Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P.
Purchase (P): 479,847 @ $10.42EDGAR
2025-12-224Kalaris Therapeutics, Inc. (KLRS)
jointly with AKKARAJU SRINIVAS, Samsara Opportunity Fund, L.P.
Grant/award (A): 1,500,000 @ $10EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2086456 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →